Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer E García-Martínez, GL Gil, AC Benito, E González-Billalabeitia, ... Breast cancer research 16, 1-17, 2014 | 270 | 2014 |
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy T Yamazaki, A Kirchmair, AI Sato, A Buqué, M Rybstein, G Petroni, N Bloy, ... Nature immunology 21 (10), 1160-1171, 2020 | 238 | 2020 |
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective … A Carmona-Bayonas, P Jiménez-Fonseca, J Virizuela Echaburu, ... Journal of Clinical Oncology 33 (5), 465-471, 2015 | 179 | 2015 |
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients A Carmona-Bayonas, J Gómez, E González-Billalabeitia, M Canteras, ... British journal of cancer 105 (5), 612-617, 2011 | 103 | 2011 |
Association of anthracycline‐related cardiac histological lesions with NADPH oxidase functional polymorphisms A Cascales, F Pastor‐Quirante, B Sánchez‐Vega, G Luengo‐Gil, J Corral, ... The oncologist 18 (4), 446-453, 2013 | 71 | 2013 |
Angiogenic role of miR-20a in breast cancer G Luengo-Gil, E Gonzalez-Billalabeitia, SA Perez-Henarejos, ... PLoS One 13 (4), e0194638, 2018 | 68 | 2018 |
Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy MAV Conesa, E Garcia-Martinez, EG Billalabeitia, AC Benito, TG Garcia, ... The Breast 21 (4), 468-474, 2012 | 65 | 2012 |
Atrial fibrillation in active cancer patients: expert position paper and recommendations T Lopez-Fernandez, A Martin-Garcia, IR Rabadán, C Mitroi, PM Ramos, ... Revista Española de Cardiología (English Edition) 72 (9), 749-759, 2019 | 64 | 2019 |
Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation A Cascales, B Sánchez-Vega, N Navarro, F Pastor-Quirante, J Corral, ... International journal of cardiology 154 (3), 282-286, 2012 | 61 | 2012 |
Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma FA De La Peña, K Kanasaki, M Kanasaki, N Tangirala, G Maeda, R Kalluri Journal of Biological Chemistry 286 (23), 20778-20787, 2011 | 61 | 2011 |
SEOM clinical guidelines in early stage breast cancer (2018) F aYaLa dE La PEña, R Andrés, JA Garcia-Saenz, L Manso, M Margelí, ... Clinical and Translational Oncology 21, 18-30, 2019 | 54 | 2019 |
SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018) A Carmona-Bayonas, P Jimenez-Fonseca, EM de Castro, E Mata, ... Clinical and Translational Oncology 21, 75-86, 2019 | 52 | 2019 |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index A Carmona-Bayonas, P Jiménez-Fonseca, C Font, F Fenoy, R Otero, ... British journal of cancer 116 (8), 994-1001, 2017 | 48 | 2017 |
Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase G Luengo-Gil, MI Calvo, E Martín-Villar, S Águila, N Bohdan, AI Antón, ... Scientific reports 6 (1), 27544, 2016 | 45 | 2016 |
Loss of β1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype K Kanasaki, W Yu, M Von Bodungen, JD Larigakis, M Kanasaki, ... The FASEB Journal 27 (5), 1950, 2013 | 41 | 2013 |
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy E García-Martínez, M Smith, A Buqué, F Aranda, FA Peña, A Ivars, ... Oncoimmunology 7 (6), e1433982, 2018 | 40 | 2018 |
Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes P de la Morena Barrio, MÁV Conesa, E González-Billalabeitia, E Urrego, ... Journal of the National Comprehensive Cancer Network 13 (4), 417-423, 2015 | 39 | 2015 |
Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables A Ivars Rubio, JC Yufera, P de la Morena, A Fernández Sánchez, ... Scientific reports 9 (1), 16979, 2019 | 36 | 2019 |
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy G Luengo-Gil, E García-Martínez, A Chaves-Benito, P Conesa-Zamora, ... Cellular Oncology 42, 627-644, 2019 | 36 | 2019 |
Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: preliminary results D Flores-Funes, J Aguilar-Jiménez, M Martínez-Gálvez, MJ Ibáñez-Ibáñez, ... Surgical oncology 30, 52-57, 2019 | 35 | 2019 |